Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Shenzhen Sangel Venture

Status
Global HQ
China
Countries of investment
    Investment stages
      Industries
        About
        Sangel Capital is a leading biomedical venture capital firm in China, focusing on innovative life science investments to cultivate industry benchmarks.
        Min check size
        -
        Max check size
        -
        Fund size
        NPS

        Investment Thesis

        Lead investor
        Co Invest
        Number of exits
        Preferred contact method

        Manager's Experience

        With extensive expertise in venture capital, the fund manager actively invests in technology and manufacturing sectors, primarily focusing on the Asia-Pacific region. Over the years, they have completed over 30 strategic deals, emphasizing early-stage investments. Their operator-first approach has led to notable exits that showcase a strong commitment to scaling innovative startups. The manager leverages data-driven insights to refine investment strategies, ensuring alignment with emerging market trends.
        Fund number
        Vintage Year
        Net Internal Rate of Return
        Investment Multiple
        Capital Allocation
        Management Fee
        Carried Interest
        AUM
        Follow-on Investments
        Graduation Rate
        Write-Off Ratio
        Last profile update timestamp